123I-IMP SPECT Brain Imaging in Epileptic Psychosis: A Study of Two Cases of Temporal Lobe Epilepsy with Schizophrenia-Like SyndromeJibiki I. · Maeda T. · Kubota T. · Yamaguchi N.
Department of Neuropsychiatry, Kanazawa University School of Medicine, Ishikawa Prefecture, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
To examine the relationship between functional abnormality of the brain and the development of epileptic psychosis, regional cerebral blood flow (rCBF) patterns with single photon emission computed tomography (SPECT) using N-isopropyl-(iodine-123)-p-Modoamphetamine (123I-IMP) were serially examined in interictal stages with and without the psychotic state in 2 medicated patients with temporal lobe epilepsy with schizophrenia-like syndrome. Both patients had epileptic EEG foci in the left temporal lobe and schizophrenialike syndrome in Bruens’ classification of epileptic psychosis, mainly consisting of auditory hallucinations and delusions of persecution and reference accompanying the enhancement of interictal epileptic discharges. In both patients, the SPECT scans obtained in the stages without the psychotic state revealed focal hypoperfusion images in the left temporal lobe regionally consistent with the EEG foci. On the other hand, the SPECT scans in the stages with the psychotic states revealed focal hyperperfusion images in the left temporal lobe or amygdala in case 1, and a normal perfusion pattern without asymmetric images of the right and left temporal lobes in case 2. These results suggest that temporo-limbic dysfunction, in particular hyperfunction in the temporo-limbic system in the left dominant hemisphere, arises at the time of the psychotic state in epileptic psychosis.
© 1993 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.